Celcuity CELC
NASDAQ CELC
$79.52 +2.14 (+2.77%)
At close: Sep 30, 2026 · 4:00 PM EDT

Celcuity (CELC) Change in Working Capital (2021)

Updated

Celcuity (CELC) recorded Change in Working Capital of $197,211 in Q1 2021.

Analysis

Celcuity (CELC) Change in Working Capital (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Working Cap. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -423.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 232.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.82 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Celcuity 3.89 Bn 3.89 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 197,211.00
API Access

Celcuity Change in Working Capital API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-working-capital&ticker=CELC&period=max&api_key=YOUR_API_KEY